CytoDyn Inc (OTCPK:CYDY)
$ 0.1246 -0.0024 (-1.89%) Market Cap: 151.99 Mil Enterprise Value: 159.16 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Cytodyn Inc at Lee Kelso discusses Leronlimab on WOWO radio Transcript

May 20, 2020 / NTS GMT
Release Date Price: $3.12 (-1.27%)
Pat Miller
WOWO - Moderator

No, I asked Lee to come on today because he forwarded some information to me about leronlimab. When you say what, leronlimab, l-e-r-o-n-l-i-m-a-b, I'm not a scientist. I got on the Google, and I had Siri tell me how to say it.

Questions & Answers

Pat Miller
WOWO - Moderator

But leronlimab or PRO 140. This is something that seems, Lee, at least at the outset, might be giving us some promising results. What is it? How far are they in looking at it? And does this give us some additional hope?

Lee Kelso
Stream Studio, LLC - Moderator

Yes, yes, and yes. So I reached out to you, Pat, because I study COVID, just it's ridiculous. The amount of time that I spend looking at things and I watched the presentation on this drug. It's a monoclonal antibody and it struck me because it is proving effective in people with renal failure and organ transplants who are [immunocompromised].

Exactly, so I was thinking of you and dropped you a little note that said, hey, you need to know about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot